PolyomavirustumorantigenshaveaprofoundeffectongeneexpressioninmouseﬁbroblastsBrittaKlucky1,3,BirgitKoch1,3,4,MartinRadolf2,PeterSteinlein2andErhardWintersberger*,11InstituteofMedicalBiochemistry,DivisionofMolecularBiology,MedicalUniversityofVienna,Dr.Bohrgasse9,A-1030Vienna,Austria;2InstituteofMolecularPathology,A-1030Vienna,AustriaPolyomavirus(Py)largeandsmalltumorantigensto-getherarecompetenttoinduceSphaseingrowth-arrestedmouseﬁbroblasts.Thecapacityofthelargetumorantigentobindthepocketproteins,pRB,p130andp107,isimportantforthetransactivationofDNAsynthesisenzymesandthecyclinsEandA,whiletheinterferenceofsmalltumorantigenwithproteinphosphatasePP2Acausesadestabilizationofthecdk2inhibitorp27,andthusleadstostrongcyclinE-andcyclinA-dependentcdk2activity.Pysmalltumorantigen,inaddition,isabletotransactivatecyclinA.Hence,thisproteinmighthaveamuchwidereffectongeneexpressioninarrestedmouseﬁbroblaststhanhithertosuspected.ThismayhaveaprofoundpartintheknowncapacityofPytoformtumorsinmice.Therefore,itwasinterestingtogainaninsightintothespectrumoftranscriptionalderegulationbyPytumorantigens.Accordingly,weperformedmicroarrayanalysisofquiescentmouseﬁbroblastsintheabsenceandpresenceofsmallorlargetumorantigen.WefoundthattheviralproteinscaninduceorrepressagreatvarietyofgenesbeyondthoseinvolvedintheSphaseinductionandDNAsynthesis.Theresultsofthemicroarrayanalysiswereconﬁrmedforselectedgenesbyseveralmethods,includingreal-timePCR.Interestingly,amutationofthebindingsiteforpocketproteinsincaseofLTandforPP2AincaseofSThasavariableeffectonthederegulationofgenesbytheviralproteinsdependingonthegeneinquestion.Infact,somegenesaretransacti-vatedbyLTaswellasSTcompletelyindependentofaninteractionwiththeirmajorcellulartargets,pocketproteinsandPP2A,respectively.Oncogene(2004)23,4707–4721.doi:10.1038/sj.onc.1207640Publishedonline3May2004Keywords:Tantigens;microarray;geneexpressionIntroductionPolyomavirus(Py)canformsolidtumorsinmanydifferentorgansofnewbornmiceandthusmustbeabletoinfectandreplicateinagreatvarietyofcelltypes(Benjamin,2001).Suchcellsareindiversestagesofdifferentiationandaremostfrequentlygrowtharrested.AsthevirusrequirescellsintheSphaseforthereplicationofitsownDNA,itmustbeabletodrivetheinfectedcellsoutofthequiescentstateintotheSphase.Thisisaccomplishedbytheactivityofthreeearlyviralproteins,thelarge,middleandsmalltumorantigens(henceforthabbreviatedLT,MTandST,respectively).LTisapleiotropicproteinthatspeciﬁcallybindstotheviraloriginofreplicationandcarrieshelicaseactivity.Initsreplicationcapacity,itcombinesfunctionsoftheORCsandtheMCMs(BellandDutta,2002)ofthecellularreplicationmachinery.Inaddition,itisthemajorproteininvolvedincreatingoptimalconditionsforvirusreplicationinthehostcellbyinterferingwiththecellularmechanismsofgrowthcontrol(Moran,1993).Itbindstotheunderphosphorylatedformofthe‘pocketproteins’,p130,p107andp110theretinoblas-tomaprotein(pRB),therebyobstructingthefunctionoftheseproteinsasnegativeregulatorsofmembersofthetranscriptionfactorfamilyE2F.ThisleadstothetranscriptionofavarietyofgeneswhoseproductsplayaroleinDNAreplication(DNAsynthesis-andprecursor-producingenzymes(Ogrisetal.,1993b;Mudraketal.,1994)andintheinitiationandpropaga-tionoftheSphase(cyclinsEandA,Schu¨chneretal.,2001).MTantigenisthemajortransformingproteinofPy.Itinteractswithproteinphosphatase2A(PP2A)andseveralproteinsattheinnersurfaceofthecellmembrane,therebyinitiatingsignaltransductionpath-ways,includingantiapoptoticones(GottliebandVillarreal,2001).Therefore,ithasbeensuggestedthatMTmightservetopreventapoptosis.IncaseofSV40,thisismediatedbytheLTantigenthatbindsandinactivatesp53,acapacitylackinginPyLTprotein(Pipas,1992).InconjunctionwithLTantigen,STofpolyomavirusandofSV40areessentialfortheinitiationoftheSphaseinserum-starvedSwiss3T3cells(Ogrisetal.,1992)andhumandiploidﬁbroblasts(Porrasetal.,1999),respectively.STprotein,likeMT,interactswiththecellularproteinphosphatasePP2A(Campbelletal.,1995),replacingtheBsubunitoftheReceived22August2003;revised5February2004;accepted9February2004;Publishedonline3May2004*Correspondence:EWintersberger;E-mail:Erhard.Wintersberger@univie.ac.at3Theseauthorscontributedequallytothiswork4Presentaddress:InstituteofMolecularPathologyOncogene(2004)23,4707–4721&2004NaturePublishingGroupAllrightsreserved0950-9232/04$30.00www.nature.com/onctrimericenzymewithconsequencesforitsactivityandspeciﬁcity.ThisfunctionplaysanimportantroleintheactivationofthecyclinEandcyclinA-speciﬁcproteinkinase,cdk2.STaccomplishesthisbycausingashiftofthecdkinhibitorp27toitsphosphorylatedform,whichisfollowedbyarapiddestructionofp27bytheubiquitin–proteasomesystem(Schu¨chnerandWinters-berger,1999).Therefore,itisnotsurprisingthatSTisalsomandatoryforthetumorigenictransformationofhumandiploidcells(Hahnetal.,1999)togetherwithLTprotein,mutatedRasandtelomerase(Yuetal.,2001;Hahnetal.,2002).Inthiscontext,itishoweverimportanttorememberthatSTantigensfromPyandfromSV40werealsofoundtocontributetothetransactivationofcyclinA(Porrasetal.,1996;Schu¨chneretal.,2001).STproteinfromSV40hadpreviouslybeenfoundtobecapableoftransactivation,buttheearlierworkconcernedviralpromoters(Loekenetal.,1988;BikelandLoeken,1992;Loeken,1992).ItwasthereforeofinteresttoﬁndoutifSTcanmorewidelyinﬂuencethetranscriptionalpotentialofcells.Itisnoteworthythatboth,LTandST,evolvedtointeractwithwidelyusedregulatorsofcellgrowth,thepocketproteinsandPP2A,respectively.Theseinterac-tionsassurethattherequirementsforvirusmulti-plicationcanbeprovidedbutatthesametimemakesitlikelythatavarietyofreactions,notnecessarilylinkedtoSphaseinduction,willalsobederegulatedbytheviralproteinswithunforeseenconsequencesforthecell.InordertoapprehendthepotentialofPyTantigenstoaffectthetranscriptionalprogrammeofmouseﬁbro-blasts,wecarriedoutamicroarrayanalysisongeneexpressioninquiescentcellsintheabsenceandinpresenceoftheviralprotein.WediscoveredthatTantigenscaninduceorinhibittheexpressionofasurprisinglylargenumberofgenes.ExamplesofsuchgeneswerestudiedinmoredetailandtheeffectofSTontheirexpressionwascomparedtothatoftheLTprotein.ResultsanddiscussionMicroarrayanalysisWehavepreviouslyproducedcelllines(onthebasisofmurineSwiss3T3cells)thatcontaintheinformationforPyLTorSTantigenunderthecontrolofthedexamethasone-responsiveMMTVpromoter(Ogrisetal.,1992).Thesecellsdonotproducetheviralproteinifgrownintheabsenceofthehormone.Afteradditionofdexamethasonetoaﬁnalconcentrationof1mmol/l,viralproteinsbecomedetectableafter4handreachhighlevelsafterabout8h;levelsofTantigenremainhighupto48hafterhormoneaddition.Thelevelofviralproteinreachedundertheseconditionsappearstocorrespondapproximatelytothatproducedininfectedcells.Lowerconcentrationsofdexamethasoneleadtolessviralprotein,whichincaseofLTsufﬁcesfortransactivationbutisinsufﬁcienttoallowthereplicationofaplasmidcarryingaviraloriginofreplication(Ogrisetal.,1993a).Fromthisresultwecanexcludethatourcellsproducelevelsofviralproteinthatarefarbeyondthoseachievedinvirusinfection.Thiscellsystemenabledustostudygeneexpressionwithinthesameserum-starved,quies-centcellsintheabsenceorinpresenceofTantigen.WeusedamousecDNAmicroarraycontainingabout17000cDNAstosearchforgeneswhoseexpressionisalteredbyPySTandPyLT.Cellsweremadequiescentbyserumstarvationfor72handtheculturewasthendividedintotwoequalparts.OnewasusedtoisolateRNAfromnormalquiescentcellskeptintheabsenceofTantigen,thesecondonereceiveddexamethasoneto1mmol/ltoinducetheviralproteinandRNAwasextracted28hlater.ThistimepointwaschosenbecauseearlierworkhadshownthatitcorrespondstotheonsetoftheSphaseincellsexpressingSTandLTproteinstogether(Ogrisetal.,1992).Tantigenexpressionwasdeterminedpriortoandafterhormoneadditioninordertoassuretheexpectedabsence(beforehormonetreat-ment)andpresence(afterhormonetreatment)ofviralprotein(Figure1).Swiss3T3cellscontainingnoviralinformationservedasacontrolforeffectsofdexa-methasonethatwerenotduetotheactivityofTantigen.TotalRNAwasusedforthepreparationofcDNAthatwastherebylabelledwithCy3-dUTPorCy5-dUTP,respectively.ThelabelledcDNAswereusedforhybri-dizationinthemicroarrayanalysis.TheexperimentwasFigure1ControlofT-antigenexpression.Cellswerearrestedfor72handthenincubatedinthepresence(þDex)orintheabsence( Dex)ofdexamethasone(1mmol/lﬁnalconcentration).RNAorproteinwasextractedfromthesecellcultures28hafterinductionofTantigen.Serum-starvedSwiss3T3cells(plusorminusdexamethasone)wereusedasanegativecontrolandb-actinservedasaloadingcontrol.RT–PCR(upperpart)wasperformedwithtotalRNAfromcellsexpressing(þDex)ornotexpressing( Dex)LTorSTantigen.Westernblotanalysis(lowerpart)ofproteinextractsusinganantibodyagainsttheN-terminusofPyTantigens.3T3areSwiss3T3cells,LTareSwiss3T3cellsexpressingLTunderthecontroloftheMMTVpromoter,STare3T3cellsexpressingSTunderthecontroloftheMMTVpromoter.LTRb-cellsexpressamutantofLTantigen(E146N)defectiveinbindingpocketproteins;PP2A-cellsexpressamutantofSTprotein(Ins107AL)defectiveinbindingPP2AModiﬁcationofgeneexpressionbyTantigensBKluckyetal4708Oncogenecarriedouttwicewherebycolorinversionwasper-formed.Genes,whoseexpressionwassigniﬁcantlychangedsolelybyadditionofdexamethasoneto3T3cellsintheabsenceofviralprotein,wereeliminatedfromourselection.Geneswereconsideredasregulatedwhenthepresenceoftheviralproteinresultedinatwo-foldorhigherup-ordownregulation.Undertheseconditions,PySTwasobservedtoupregulate281andtorepress242ofthegenesrepresentedbythemicroarray.TheupregulatedgenesarelistedingroupsaccordingtofunctioninTable1;thedownregulatedgenesareshowninTable2.TheresultsofanidenticalmicroarrayanalysiscarriedoutwithcellsexpressingLTantigenareshowninTables3and4.LTexpressionresultedinanupregulationof222genesandadownregulationof157ofthegenesonourarray.Microarraydataoncellsstimulatedbyadditionofserumwerecarriedoutforcomparison.Here,thetimepointchosenwas18h,whichaccordingtoFACSanalysiscorrespondstotheonsetoftheSphaseinserumstimulatedcells,andhenceapproximatesthe28hpointinquiescentcellsexpressingTantigens.Atthistime,serumadditioninducedtheexpressionof643genesandrepressed537genesonourarray.(Thedataareavailableonrequest).SeveralgenesinducedorrepressedbySTandLTwereselectedforconﬁrmationandextensionofthemicroarraydatabydetailedanalysis.Weﬁrstusedsemiquantitativereversetranscription–polymerasechainreactions(RT–PCR)orimmunoblottingifantibodyagainsttheproteinwasavailabletoconﬁrmtheeffectsoftheviralproteinsusingthe28htimepoint.Consideringthatthistimepointmaynotalwaysrevealtheoptimalinductionorrepressionaccomplishedbytheviralprotein,wethencarriedoutreal-timePCRreactionsonRNAisolated8,18and28hafterinductionoftheviralprotein.Theseseriesofreactionswerecarriedoutwithcellsexpressingwild-typeLTorSTproteinaswellastheLTmutantlackinganinteractionwithpocketproteinsandanSTmutantdefectiveinbindingPP2A.Furthermore,theeffectofdexamethasoneonarrestedSwiss3T3cellsnotcarryinginformationforviralproteinwasalsodeter-mined8,18and28hafteradditionofhormone.Forreasonsofclarity,weshowonlythosedataforthemutantsthatcorrespondtothetimepointswhereoptimaleffectswereattainedwiththewild-typeproteinsandweshowonlythelongest,thatis,the28htimepointfor3T3cellstreatedwithdexamethasone.Moreover,fortwoupregulatedgenes,namelythosecodingforMCM6andMCM7,promoter-luciferaseconstructswerepro-ducedandpromoteractivationwasstudiedaftertransientco-transfectionwithTantigen.ConﬁrmationofmicroarraydataforselectedgenesGenesupregulatedbyviralproteinsFromthegroupsdepictedinTables1and2,weﬁrstselectedexamplesofgeneswhoseproductsareinvolvedintheprogressionoftheG1phaseofthecellcycleandthosethathaveafunctionduringtheSphaseforfurtheranalysis.Thisselectionincludedgeneswhoseexpressionwasderegu-latedtodifferentdegreesbytheviralprotein.Usinginadditiontothewildtype,amutantofSTunabletointeractwithPP2A,itwasobservedthatthismutationaffectstheactivityofSTonallofthegenesexamined,albeittoavariabledegree,dependingonthegeneexamined.Forinstance,whiletheinductionofcyclinD1andthatofc-mycisreducedby80–100%iftheinteractionsiteforPP2Awasmutated,thetransactiva-tionofmcm6andmcm7ismuchlessdependentonaninteractionwithPP2A.Inthiscase,thePP2A-mutantexhibited40%ormoreoftheactivityofthewild-typeST.ItislikelythatatleastthatpartofthecapacitiesofSTthatdoesdependonaninteractionwithPP2Ainﬂuencespromoteractivityindirectly,byderegulatingsignaltransductionpathways(Sonntagetal.,1993;Frostetal.,1994)orbycausingamoredirectchangeinthephosphorylationstatusoftranscriptionalregulators.ThesituationisquitesimilarinthecaseofthedependenceofLTfunctionsonanintactbindingsiteforpocketproteinsexceptthatinthiscasesomeofthegeneschosenwerederegulatedcompletelyindependentofaninteractionofLTwithpocketproteins.ItshouldbepointedoutthatinallexperimentsweusedoneandthesamecelllinesharboringthemutatedversionsofeitherSTorLT.Thevariabilityoftheeffectofthemutationsthereforecannotbeattributedtodifferencesinthecelllinesused.Rather,itindicatesthatSTaswellasLTcantransactivateorrepresscertaingenesbyamechanismindependentofaninteractionwithPP2Aorpocketproteins,respectively.TheseobservationsonindividualgenesagreewellwiththedataobtainedonmicroarrayanalysiscarriedoutwiththePP2AmutantofSTandthepocketproteinmutantofLT,respectively(availableonrequest).Thesedatarevealednotonlyareducedeffectondiversgenesthatareup-ordown-regulatedbytheviralproteins,buttheyinadditiondisclosedgenesthatarederegulatedonlyifthemajorinteractionofLTorSTwaseliminatedbymutation.WhilenothingisknownofpotentialinteractionsofSTwithcellularpartnersotherthanPP2AandchaperonesofthednaKtype,interactionsinadditiontothoseinvolvingpocketproteinsandchaperonesareknownforLT.Forinstance,SV40LTwasreportedtointeractwithcomponentsofthegeneraltranscriptionmachinery(Damaniaetal.,1998).AlthoughsuchaninteractionwasnotsofarshownorlookedforinPyLTantigen,thefunctionalsimilaritybetweenSV40andpolyomaLTsuggeststhatitmaywellexist.Ifso,itislikelytocontributetothetransactivatingcapacityofthisviralprotein.Furthermore,LTproteinsofbothSV40andpolyomaviruswerepreviouslyshowntobindtheco-activatorproteinCPB/p300(Eckneretal.,1996;NemethovaandWintersberger,1999),whichagainmayinﬂuencegeneexpressionindependentofaninteractionwithpocketproteins.WhilethecyclinsEandAwerefoundearliertobetransactivatedbyLTandST,thisstudyincludescyclinD1asafurthertargetforSTantigen.RT–PCRandreal-timePCR(Figure2)supportthedataobtainedinthemicroarrayanalysis.ThisresultisinaccordwithareportonSV40STprotein,whichwasalsoobservedtoinducecyclinD1expressioninamannerdependentonModiﬁcationofgeneexpressionbyTantigensBKluckyetal4709OncogeneTable1Genesinducedtwo-foldorhigherbyPysmallT-antigenincDNAmicroarrayGenBankClonedescriptionFoldinductionCellcycleregulatorsandDNAsynthesisgenesAI850048CyclinD12.53AI323675PCTAIRE-motifproteinkinase32.02AI840227Minichromosomemaintenancedeﬁcient7(S.cerevisiae)2.01AI854509Minichromosomemaintenancedeﬁcient6(S.cerevisiae)2.02AI849847Proliferatingcellnuclearantigen2.06AI840542RAD21homolog(S.pombe)2.30Oncogenes,tumorsuppressors,stressandapoptosisgenesAI849916Polymyositis/sclerodermaautoantigen14.54AI841358Heatshock70kDaprotein84.40AI850962TransducerofERBB2,24.39AI845078Smallproteineffector1ofCdc424.04AI528587c-merproto-oncogene3.88AI841755Aplysiaras-relatedhomologB(RhoB)3.86AI842320Neuroﬁbromatosis23.37AI844365Bcl2-like2.90AI836493Myelocytomatosisoncogene(c-myc)2.88AI848789B-cellCLL/lymphoma7C2.70AI838486Heatshockprotein,105kDa2.67AI852670Cerebralcavernousmalformations12.39AI836313Heatshockprotein,86kDa12.18AI844691Tumordifferentiallyexpressed12.16AI845042AnnexinA52.13AI842572Rho,GDPdissociationinhibitor(GDI)beta2.12AI528760ColdshockdomainproteinA2.09Genesinvolvedintranscription,translation,immuneresponseanddegradationpathwayAI841501RibosomalproteinS3a3.86AI845964RibosomalproteinS173.36AI853670Leucinezipperprotein13.24AI464459CytokineinducibleSH2-containingprotein23.19AI835282Eucaryotictranslationelongationfactor1beta23.14AI662267Homeodomaininteractingproteinkinase13.13AI845514ATP-bindingcassette,subfamilyA(ABC1),member12.99AI843614Retinolbindingprotein1,cellular2.90AI840032Translationallyregulatedtranscript(21kDa)2.86AI836784Splicingfactor,arginine/serine-rich5(SRp40,HRS)2.82AI836484RNAbindingmotifprotein,Xchromosome2.78AI835939Eucaryotictranslationelongationfactor1alpha12.57AI852094Polybindingprotein,cytoplasmic12.47AI323595B-cellreceptor-associatedprotein312.39AI849117RibosomalproteinL10A2.37AI413443Ubiquitin-conjugatingenzymeE2G22.36AI850137Nucleolin2.29AI841821Ia-associatedinvariantchain2.26AI844203Eucaryoticelongationfactor-2kinase2.21AI851284Interferon-relateddevelopmentalregulator12.19AI850329Highmobilitygroupbox12.18AI839283InhibitorofDNAbinding32.10AI852144Pre-B-cellcolony-enhancingfactor2.08AI852911Kruppel-likefactor152.07AI847690RibosomalproteinS4,X-linked2.06AI850396Nuclearfactor,erythroidderived2,-like12.04AI323569Zinc-ﬁngerhomeobox1a2.03AI836652UbiquitinB2.01Cellsurface,signaltransduction,cytoskeletonandmetabolismproteinscontinuationAI853846Fattyacidbindingprotein5,epidermal4.47AI847285Mitogen-activatedproteinkinasekinasekinase64.41AI845630Tyrosine3-monooxygenase/tryptophan5-monooxygenaseactivationprotein4.36AI836976Glutamatedehydrogenase4.06AI848830Isocitratedehydrogenase2(NADP+),mitochondrial3.97AI835559Thymopoietin3.65AI847745Phosphataseandtensinhomolog3.51AI839581Porcupinehomolog(Drosophila)3.46AI427514Metallothionein13.33AI841644Guaninenucleotidebindingprotein,beta2,relatedsequence13.24AI838964Syntrophin,acidic13.16AI845452Procollagen,typeXI,alpha23.10ModiﬁcationofgeneexpressionbyTantigensBKluckyetal4710OncogeneTable1(continued)GenBankClonedescriptionFoldinductionCellsurface,signaltransduction,cytoskeletonandmetabolismproteinscontinuationAI849502Amyloidbeta(A4)precursor-likeprotein23.08AI836893Lamininreceptor1(67kDa,ribosomalproteinSA)3.08AI853686Glutamatereceptor,ionotropic,AMPA3(alpha3)3.01AI851272Dualspeciﬁcityphosphatase143.00AI839368Carbonylreductase12.97AI845051Beta-spectrin32.93AI845046Trans-Golginetworkprotein12.93AI851776MyosinIc2.90AI840685Lysosomalmembraneglycoprotein12.90AI847962Transmembrane4superfamilymember22.86AI844634Actin,alpha1,skeletalmuscle2.82AI849308Glutaredoxin1(thioltransferase)2.80AI840364Neuralprecursorcellexpressed,developmentallydownregulatedgene4b2.77AI840657Silica-inducedgene812.75AI844844Receptor(calcitonin)activitymodifyingprotein22.75AI385536Cadherin22.71AI841041Huntingtin-associatedprotein12.64AI854038SH3domainprotein52.61AI836919Crystallin,alphaB2.60AI845273Aspartate-beta-hydroxylase2.59AI846934Lipin12.59AI849894Guaninenucleotidebindingprotein,beta22.59AI847216Cytochromecoxidase,subunitVIa,polypeptide12.57AI847216Nucleophosmin12.57AI844017Aldo-ketoreductasefamily1,memberB3(aldosereductase)2.53AI847207Microspheruleprotein12.52AI843247Dopaminereceptor42.48AI450702ATPase,Na+/K+transporting,beta3polypeptide2.47AI850974Phosphatidylinositol3-kinase,reg.subunit,polypeptide1(p85alpha)2.46AI854176Muscleblind-like(Drosophila)2.42AI841957Gamma-aminobutyricacid(GABA-A)receptor,subunitalpha62.39AI838730Popeye32.37AI851805Platelet-derivedgrowthfactor,Cpolypeptide2.31AI325068Solutecarrierfamily25(mitoch.carrier;adeninenttranslocator),member52.29AI839744Growtharrestspeciﬁc12.28AI851616PyruvatedehydrogenaseE1alphasubunit2.27AI851427Proteinkinase,cAMP-dependentregulatory,typeIIbeta2.26AI843104Fibroblastgrowthfactorinducible142.26AI854743Adenylatekinase3alphalike2.25AI853659Cut(Drosophila)-like12.25AI851564Acetyl-CoenzymeAdehydrogenase,long-chain2.24AI843768Amyloidbeta(A4)precursorprotein2.23AI427644Epidermalgrowthfactorreceptor2.23AI836347Tubulinalpha22.22AI852430Peripheralmyelinprotein,22kDa2.21AI841311Microtubule-associatedprotein1lightchain32.21AI414231Villin2.19AI842086Basigin2.18AI840757Tubulinalpha12.18AI840676Beta-spectrin2,nonerythrocytic2.18AI853695Integrin-associatedprotein2.18AI852827Catechol-O-methyltransferase2.14AI847067Neuralprecursorcellexpressed,developmentallydownregulatedgene4a2.14AI835817Thymusexpressedacidicprotein2.13AI849996Latexin2.12AI844775Thioredoxin2.10AI848212Fumarylacetoacetatehydrolase2.10AI844421Tissueinhibitorofmetalloproteinase22.10AI841941Tetratricopeptiderepeatdomain2.10AI845316Stearoyl-coenzymeAdesaturase22.07AI834834Gprotein-coupledreceptor,familyC,group5,memberB2.03AI843656ProteinkinaseC,delta2.02AI853012CystatinB2.02AI850110WDrepeatdomain12.00AI839138Upregulatedby1,25-dihydroxyvitaminD-32.00152ESTswithunknownfunctionModiﬁcationofgeneexpressionbyTantigensBKluckyetal4711OncogeneTable2Genesrepressedtwo-foldorhigherbyPysmallT-antigenincDNAmicroarrayGenBankClonedescriptionFoldrepressionCellcycleregulatorsandDNAsynthesisgenesAI323295DNA-damageinducibletranscript32.17Oncogenes,tumorsuppressors,stressandapoptosisgenesAI838312Decorin9.13AI851574Melanomaantigen,familyD,24.70AI450810Promyelocyticleukemia3.81AI842716CytochromeP450,512.58AI842612Melanocyteproliferatinggene12.04Genesinvolvedintranscription,translation,immuneresponseanddegradationpathwayAI854552Interferon-inducedproteinwithtetratricopeptiderepeats39.28AI854626Lymphocyteantigen6complex6.19AI838634Ubiquitin-speciﬁcprotease255.10AI449282Interferon-inducibleGTPase4.22AI848402Histocompatibility2,Tregionlocus103.34AI836367TAPbindingprotein2.93AI836233Proteasome(prosome,macropain)subunit,betatype102.86AI838322SmallinduciblecytokineA21a(leucine)2.81AI451137Interferonactivatedgene2032.77AI528519Complementcomponent32.70AI528713Interferongammainducibleprotein,47kDa2.64AI428543Zinc-ﬁngerprotein2612.63AI447752Nuclearreceptorsubfamily3,groupC,member12.60AI853915Guaninenucleotidebindingprotein,beta42.58AI851597Eucaryotictranslationelongationfactor1alpha22.48AI429495ATP-dependentinterferonresponsive2.43AI841665Matrixmetalloproteinase14(membrane-inserted)2.41AI852236Histocompatibility2,Dregionlocus12.36AI853714CathepsinB2.30AI853077Calpastatin2.27AI852036Nuclearreceptor-bindingSET-domainprotein12.20AI326933Ubiquitin-conjugatingenzyme82.17AI448932T-box22.14AI840449SmallnuclearribonucleoproteinD12.14AI852351MitochondrialribosomalproteinL112.14AI528521SpecialAT-richsequencebindingprotein12.05AI852357Eucaryotictranslationinitiationfactor4A22.01Cellsurface,signaltransduction,cytoskeletonandmetabolismproteinsGenBankClonedescriptionFoldRepressionAI842984TenascinC9.66AI661287Transforminggrowthfactor,betainduced,68kDa9.04AI854636Earlygrowthresponse16.81AI326106Guanylatenucleotidebindingprotein26.53AI449282Frizzledhomolog9(Drosophila)5.16AI835595Secretedphosphoprotein14.64AI836468Myristoylatedalanine-richproteinkinaseCsubstrate4.57AI844874Procollagen,typeI,alpha14.17AI850915UDP-glucoseceramideglucosyltransferase-like3.90AI836323Sortilin13.85AI848233sproutyhomolog2(Drosophila)3.84AI448916Slithomolog2(Drosophila)3.79AI842053PeptidylprolylisomeraseC-associatedprotein3.64AI847324Insulinreceptorsubstrate13.61AI449540Signaltransducerandactivatoroftranscription13.53AI853346ThymidylatekinasefamilyLPS-induciblemember3.52AI528734Stromalcellderivedfactor13.50AI450263Lectin,galactosebinding,soluble63.27AI836324CarboxypeptidaseE3.20AI465143Lectin,galactosebinding,soluble13.13AI846654Heparansulfate6-O-sulfotransferase23.08AI413932Emerin3.03AI840949Argininosuccinatesynthetase12.98AI325230Dopachrometautomerase2.79AI837432Solutecarrierfamily7(cationic,transporter),member102.74AI838652Procollagen,typeI,alpha22.71AI839177Procollagen,typeXII,alpha12.66AI844075LIMonly42.64AI385730Procollagen,typeXI,alpha12.40ModiﬁcationofgeneexpressionbyTantigensBKluckyetal4712OncogeneaninteractionwithPP2A(Watanabeetal.,1996).Immunoblotting(notshown)indicatesthatcyclinD1proteinwashighinarrestedcellsanddidnotchangesigniﬁcantlyafterTantigeninductionorserumaddi-tion,suggestingthattheproteinisratherstableinSwiss3T3cells.PyLTantigentransactivatedcyclinD1aboutsix-fold,whilethecorrespondingproteinfromSV40wasreportedtoinhibitcyclinD1expression(Lukasetal.,1994).C-mycisstronglytransactivatedbyST(Figure2),whileLThadonlyaminoreffect.Thestrongtransactivationofc-mycbySTmaybeparticularlyrelevantasc-mycmodulatestheexpressionofagreatvarietyofgenes(Colleretal.,2000;MenssenandHermeking,2002;Fernandezetal.,2003).ThisraisesthepossibilitythatSTchangestheexpressionofsomegenesthroughitseffectonc-myc.Infact,amongthegenesobservedasregulatedbyc-mycinallthreestudiesreferredtoabovearethosecodingforribosomalproteins,heatshockproteinsandnucleolin,whicharealsofoundtobeupregulatedbySTinouranalysis.ManyproteinsinvolvedinDNAsynthesisandprecursorproductionwerepreviouslyshowntobetransactivatedbyPyLT(Ogrisetal.,1993b;Mudraketal.,1994).ThisincludesPCNA,whichinthisstudywasalsofoundtobeinducedbySTprotein.Thelistalsocontainstwoimportantproteinsofcellularprereplica-tioncomplexes,MCM6andMCM7.BothoftheseproteinsweretransactivatedbyLTandSTantigens(Figure3).GenescodingforMCMproteinsareregulatedbyE2F(Tsurugaetal.,1997;Ohtanietal.,1999);theirinductionbyLTandSTmaythereforeresemblethatoftheotherE2F-controlledgenesreportedpreviously.Wehaveisolatedthemurinepromotersforthemcm6andthemcm7geneandcreatedpromoter-luciferaseconstructsfortransienttransfectionstogetherwithLTorSTortheirmutants(Figure4).Theresultsoftheseassaysconﬁrmedthoseobtainedwithreal-timePCRandRT–PCR.Inagree-mentwiththemoredirectfunctionofLTproteinonE2Fregulatedpromoters,transactivationofthesepromotersintransienttransfectionassaysisconsistentlystrongerbyLTthanbySTantigen.Consideringtheco-ordinatedregulationofallsixMCMproteins(MCM2–7)duringserumstimulationofREF52cells(Ohtanietal.,1999),itislikelythatalsotheotherMCMproteinsaretransactivatedbybothTantigens.SeveraloncogenesandtumorsuppressorsexhibitalteredexpressioninthepresenceofLTorST.AnexampleisthetumorsuppressorproteinTable2(continued)GenBankClonedescriptionFoldrepressionAI853169Stearoyl-CoenzymeAdesaturase12.37Cellsurface,signaltransduction,cytoskeletonandmetabolismproteinscontinuationAI835931BrainproteinI32.36AI427643Gliamaturationfactor,gamma2.35NAVpreB2.34AI838326Serine(orcys)proteinaseinhibitor,cladeH(hsp47),member12.26AI836826Glycoprotein382.26AI450121Peroxisomalbiogenesisfactor132.25AI836381Actin-like2.25AI840949Argininosuccinatesynthetase12.22AI847852Proteintyrosinephosphatase,receptor-type,M2.21AI448959Fibulin22.21AI853088Follistatin-like2.18AI853451Proteinkinase,cAMPdependent,catalytic,alpha2.15AI844939Openreadingframe122.15AI843816Exostoses(multiple)12.13AI847131Ankyrinrepeathookedtozinc-ﬁngermotif2.11AI449353Phosphoinositide-3-kinase,catalytic,gammapolypeptide2.10AI450719Single-strandselectivemonofunctionaluracilDNAglycosylase2.09AI450103Serineproteaseinhibitor62.09AI854719ProstaglandinEsynthase2.07AI854572Coatomerproteincomplex,subunitgamma12.07AI852039Elongationofv.l.chainfattyacids(FEN1/Elo2,SUR4/Elo3,yeast)-like12.07AI893625Syndecan22.07AI844799Phosphatidylinositolmembrane-associated2.04AI847778N-acetylgalactosaminidase,alpha2.04AI846240Phosphatidylinositol3kinase,regulatorysubunit,polypeptide4,p1502.03AI893646Proteintyrosinephosphatase,receptortype,K2.03AI840537Cadherin112.02AI843939Adenylatekinase12.02AI323769Ceruloplasmin2.02AI853322Proteintyrosinephosphatase,receptortype,S2.01AI842633HumanimmunodeﬁciencyvirustypeIenhancer-bindingprotein12.00148ESTswithunknownfunctionModiﬁcationofgeneexpressionbyTantigensBKluckyetal4713OncogeneTable3Genesinducedtwo-foldorhigherbyPylargeT-antigenincDNAmicroarrayGenBankClonedescriptionFoldinductionCellcycleregulatorsandDNAsynthesisgenesAI840227Minichromosomemaintenancedeﬁcient7(S.cerevisiae)4.00AI854509Minichromosomemaintenancedeﬁcient6(S.cerevisiae)3.56AI894115CyclinD13.48AI849847Proliferatingcellnuclearantigen3.03AI837745Telomerasebindingprotein,p232.72AI849171Polymerase(DNAdirected),delta2,regulatorysubunit(50kDa)2.58AI840088ReplicationproteinA22.44AI846943Cyclin-dependentkinase42.32AI844106Thymidylatekinase2.32AI838819MYBbindingprotein(P160)1a2.08Oncogenes,tumorsuppressors,stressandapoptosisgenesAI846348Hypoxiainducedgene12.93AI854800CytochromeP450,512.87AI844365Bcl2-like2.66AI836493Myelocytomatosisoncogene(c-myc)2.61AI840074Ras-GTPase-activatingprotein(GAPo1204)SH3-domain-bindingprotein22.57AI528760ColdshockdomainproteinA2.53AI838255Chaperoninsubunit6a(zeta)2.43AI429136Transforming,acidiccoiled-coilcontainingprotein32.36AI837834t-complexprotein12.25AI841137Differentiallyexpressedinbraintumors2.09AI841116Peroxiredoxin22.07AI841173Rhointeractingprotein32.06AI842297RAS-relatedC3botulinumsubstrate12.04AI854010RAS-like,family2,locus92.04AI842320neuroﬁbromatosis22.01Genesinvolvedintranscription,translation,immuneresponseanddegradationpathwayAI845040Translationallyregulatedtranscript(21kDa)3.00AI836520Histonegenecomplex22.75AI840449SmallnuclearribonucleoproteinD12.74AI836982Proteaseome(prosome,macropain)28subunit,32.56AI849860Stem-loopbindingprotein2.53AI838842RNAbindingmotifprotein32.40AI839283InhibitorofDNAbinding32.29AI843304CCAAT/enhancerbindingprotein(C/EBP),alpha2.20AI835853H2Ahistonefamily,memberZ2.12AI326849Transcriptionalregulatorprotein2.11AI464523T-box52.07AI835911HeterogeneousnuclearribonucleoproteinK2.05AI853852RibosomalproteinS182.02AI847332Interferonalpharesponsivegene,15kDa2.01Cellsurface,signaltransduction,andcytoskeletonandmetabolismproteinsAI834834Gprotein-coupledreceptor,familyC,group5,memberB5.82AI839335Adducin3(gamma)4.90AI852527Importinbeta3.64AI841020Phosphoglyceratekinase13.56AI849502Amyloidbeta(A4)precursor-likeprotein23.54AI851778Connectivetissuegrowthfactor3.44AI849308Glutaredoxin1(thioltransferase)3.43AI840757Tubulinalpha13.31AI326287Tubulinalpha83.26AI528531PyruvatedehydrogenaseE1alphasubunit3.16AI836347Tubulinalpha23.11AI840025Secretedacidiccysteine-richglycoprotein2.90AI850162Laminin,gamma12.85AI427514Metallothionein12.83AI836976Glutamatedehydrogenase2.83AI840604Tubulinalpha42.83AI854035Kelch-likeECH-associatedprotein12.82AI847285Mitogen-activatedproteinkinaseKinasekinase62.75AI835559Thymopoietin2.75AI841394Phosphoglyceratemutase12.70AI841966Proteinkinase,AMP-activated,gamma1noncatalyticsubunit2.61AI837206Prothymosinalpha2.57ModiﬁcationofgeneexpressionbyTantigensBKluckyetal4714Oncogeneneuroﬁbromatosis2(NF2)(LutchmanandRouleau,1995).Figure5showstheinductionofNF2byLTaswellasST,whichisdependentontheinteractionswithpocketproteinsandPP2A,respectively.TheNF2promoterhassomesimilaritytothecyclinApromoterwithwhichitsharesbindingsitesfortranscriptionfactorsSP1,E2FandNF-Y(Kinoetal.,2001).ThismightsuggestthatitstransactivationbythetwoTantigensmayfollowsimilarmechanisms.Surprisingly,however,andinvastcontrasttocyclinA,serumadditiondramaticallyreducedNF2expression,conﬁrm-ingtheresultsofthemicroarrayanalysisofserum-stimulatedcells.ThesamewasobservedwiththegenecodingfortheGproteincoupledreceptor(GPCR)(Figure6).Thisgene,togetherwiththeonecodingformyosin,belongstothelargegroupofgenesinthetableslistedundergenescodingforsignaltransducers,cellsurfaceproteinsandcytoskeletalproteins.BothGPCRandmyosinarealsotargetsoftheLTprotein(Figure6).GenesdownregulatedbyviralproteinsAmongthegenesthatarestronglyrepressedbySTarethosecodingfordecorinandcadherin11(Figure7).Bothoftheseproteinsarelocatedinthecellsurfaceandexhibitvariouscell-type-speciﬁceffectsduringdifferentiationandcellgrowth.Forinstance,cadherin11isupregu-latedduringmyoblasticorosteogenicdifferentiationofC3H10T1/2andC2C12.Incontrast,adipogenicdiffer-entiationofthesecellsaswellasof3T3-L1cellscausesadecreaseofcadherinexpression(Shinetal.,2000).Inhumanosteoblasts,dexamethasonewasreportedtoinhibitcadherin11expression(Lecandaetal.,2000).WefoundthatalsoinSwiss3T3cellsdexamethasoneTable3(continued)GenBankClonedescriptionFoldinductionCellsurface,signaltransduction,andcytoskeletonandmetabolismproteinscontinuationAI850901Parvin,alpha2.56AI851776MyosinIc2.50AI839899RegulatoryfactorX-associatedankyrin-containingprotein2.46AI836844Calmodulin12.46AI450702ATPase,Na+/K+transporting,beta3polypeptide2.45AI894247Tubulin,beta52.44AI849335NeighborofPuncE112.43AI844634Actin,alpha1,skeletalmuscle2.35AI448908Chlorideintracellularchannel4(mitochondrial)2.31AI851107Peripheralmyelinprotein,22kDa2.30AI845765Sterol-C5-desaturasehomolog(S.cerevisae)2.29AI843707TreacherCollinsFranceschettisyndrome1,homolog2.27AI836137Pyruvatekinase32.27AI842299LamininB1subunit12.23AI839138Upregulatedby1,25-dihydroxyvitaminD-32.21AI414231Villin2.21AI850309CoagulationfactorII(thrombin)receptor2.20AI842934Dystroglycan12.20AI849775Osteoblastspeciﬁcfactor2(fasciclinI-like)2.17AI850206Paralemmin2.15AI447993Butyrophilin-like22.14AI854752Radixin2.14AI849985Solutecarrierfamily12,member22.12AI842656Lurchertranscript12.11AI836968Alphaactinin42.11AI847067Neuralprecursorcellexpressed,developmentallydownregulatedgene4a2.09AI853464Pantophysin2.09AI845824sorbitoldehydrogenase12.08AI838504Enhancerofrudimentaryhomolog(Drosophila)2.08AI847962Transmembrane4superfamilymember22.08AI842586TroponinT2,cardiac2.07AI844511STIP1homologyandU-Boxcontainingprotein12.06AI841014Guaninenucleotidebindingprotein,alphastimulating2.06AI836349Junctophilin32.06AI841283Novelnuclearprotein12.05AI662267Homeodomaininteractingproteinkinase12.04AI385637Frizzledhomolog8(Drosophila)2.04AI836694ATPsynthase,H+transporting,mitroch.F1complex,gammapolypept.12.03AI843739FK506bindingprotein12-rapamycinassociatedprotein12.02AI841010Adeninephosphoribosyltransferase2.02AI853846Fattyacidbindingprotein5,epidermal2.02AI838959Actin,alpha2,smoothmuscle,aorta2.01119ESTswithunknownfunctionModiﬁcationofgeneexpressionbyTantigensBKluckyetal4715OncogeneTable4Genesrepressedtwo-foldorhigherbyPylargeT-antigenincDNAmicroarrayGenBankClonedescriptionFoldrepressionCellcycleregulatorsandDNAsynthesisgenesAI840919DNA-damageinducibletranscript32.45AI848752topoisomerase(DNA)IIbeta2.27Oncogenes,tumorsuppressors,stressandapoptosisgenesAI846778Decorin3.86AI852541Tumorrejectionantigengp962.46AI450853Cerebralcavernousmalformations12.45AI843677Erbb2interactingprotein2.40AI528704Rho-associatedcoiled-coilformingkinase12.26AI853115RhoGTPaseactivatingprotein52.21AI834803DnaJ(Hsp40)homolog,subfamilyB,member122.21AI846385RAB23,memberRASoncogenefamily2.06AI848314Naturalkillertumorrecognitionsequence2.05Genesinvolvedintranscription,translation,immuneresponseanddegradationpathwayAI854552Interferon-inducedproteinwithtetratricopeptiderepeats36.57AI852028Ubiquitinspeciﬁcprotease9,Xchromosome3.25AI850966TranscriptionelongationfactorA(SII)12.62AI447752Nuclearreceptorsubfamily3,groupC,member12.48AI836309Eucaryotictranslationinitiationfactor32.47AI528713Interferongammainducibleprotein,47kDa2.46AI846176Histocompatibility2,Tregionlocus102.28AI448195Trans-actingtranscriptionfactor32.26AI449282Interferon-inducibleGTPase2.24AI853077Calpastatin2.20AI841432HeterogeneousnuclearribonucleoproteinH12.05AI449004HeterogeneousnuclearribonucleoproteinA2/B12.00AI845529RibonucleaseP12.00Cellsurface,signaltransduction,andcytoskeletonandmetabolismproteinsAI847805Secretedphosphoprotein15.29AI661287Transforminggrowthfactor,betainduced,68kDa4.94AI450263Lectin,galactosebinding,soluble63.28AI528637Beta-2microglobulin3.22AI326106Guanylatenucleotidebindingprotein23.19AI842984TenascinC3.16AI893625Syndecan23.04AI840134Myristoylatedalanine-richproteinkinaseCsubstrate2.99AI842819Branchedchainaminotransferase1,cytosolic2.93AI850620Matrin32.81AI528734Stromalcellderivedfactor12.73AI838226Glycinetransporter12.45AI843323Latenttransforminggrowthfactorbetabindingprotein22.42AI854587Prolinedehydrogenase2.41AI426812Imprintedandancient2.39AI839302Clusterin2.34AI327322Chondroitinsulfateproteoglycan62.31AI850263Lysosomalmembraneglycoprotein22.31AI323554Crystallin,zeta2.30AI427643Gliamaturationfactor,gamma2.29AI851370Tetratricopeptiderepeatdomain2.27AI848700Kinesinfamilymember5B2.26AI662153Kidneyandrogenregulatedprotein2.21AI854636Earlygrowthresponse12.21AI528639Adenylatecyclase72.18AI852712Gapjunctionmembranechannelproteinalpha12.15AI846016Developmentanddifferentiationenhancing2.14AI838700LymphoidnuclearproteinrelatedtoAF4-like2.13AI839465Neuropilin2.11AI323769Ceruloplasmin2.10AI844503GTPcyclohydrolase12.09AI835169Potassiumvoltage-gatedchannel,subfamilyQ,member22.09AI853162Shortstaturehomeobox22.08AI450790Sideroﬂexin12.08Cellsurface,signaltransduction,andcytoskeletonandmetabolismproteinscontinuationAI840537Cadherin112.01AI326787Lipoproteinlipase2.01AI838607Thrombospondin12.0196ESTswithunknownfunctionModiﬁcationofgeneexpressionbyTantigensBKluckyetal4716Oncogenecausedsomedecreaseofcadherin11expression,buttheeffectofSTproteinwasbyfarstronger(Figure7),excludingthatthiseffectissolelyduetotheadditionofdexamethasonetoourcells.Decorinwasfoundtobedownregulatedinsometumors(forreviews,seeforinstanceSta¨nderetal.,1999;KresseandScho¨nherr,2001).ItbindstoTGF-bandinhibitsitsactivity.Ontheotherhand,itwasfoundtoupregulatep21expressioninsometumorcells.ItsstrongdownregulationinourSTexpressingcellscouldthuscontributetothegrowth-inducingpotentialoftheviralprotein.Interestingly,downregulationofbothofthesegenesbyLTwascompletelyindependentofaninteractionwithpocketproteins.Finally,onegroupofgeneswhoseexpressionnotunexpectedlyisaffectedbyLTandSTinvolvesgenesfortranscriptionfactorsandtranslationalregulators,im-muneresponsegenesandgeneswhoseproductsfunctionindegradationpathways.WhilecomponentsofthetranscriptionmachineryarefrequentlyupregulatedbyTantigens(seeforinstanceFelton-EdkinsandWhite,2002),manygenesoftheimmuneresponseherewerefoundtobedownregulated,thuscreatingconditionsthatwouldallowthevirustoescapethecellularimmuneresponse.Insummary,thismicroarrayanalysisdisclosedanastonishinglylargenumberofgenesthatareup-ordownregulatedaftertheexpressionofPyTantigensinquiescentcells.Allselectedgeneschosenfordocumen-tationoftheirderegulationconﬁrmedthedataobtainedbythemicroarrayanalysis.ConsideringthatthelistinTables1–4stillmissesgenesknowntocodeforSphase-Figure2InductionofcyclinD1andc-myc.Inthisandinallfurtherﬁgures,withtheexceptionofFigure4,cellsweretreatedasinFigure1.Real-timePCRandsemiquantitativeRT–PCRwereperformedwithspeciﬁcprimersasdescribedinMaterialsandmethodsFigure3InductionofMCM6andMCM7.TheprimersandantibodiesusedaredescribedinMaterialsandmethodsModiﬁcationofgeneexpressionbyTantigensBKluckyetal4717Oncogenespeciﬁcenzymesandproteinsthatwerealreadyshownorareexpectedtobetransactivatedbyviralproteins,thetotalnumberofgenesinﬂuencedintheirexpressionbyPyTantigensmaybeevenlarger.Obviously,theselectionpressureontheevolutionofPywastocreateoptimalconditionsforvirusreplicationinmanydifferentcelltypes,thatis,drivingthesedifferentcellsfromthequiescentstateintotheSphase.Thismayrequireinterferencewithdifferentmechanismsofgrowthregulationandhencewithabroadspectrumoftranscriptionalcontrolprocesses.OnemayaskwhyitneedsbothLTandSTtodriveefﬁcientlySwiss3T3cellsoutofthequiescentstateintotheSphase(Ogrisetal.,1992),whenSTaloneissuchanefﬁcientderegulatorofgeneexpression.Thereareseveralexplanationsforthis:(i)comparedwithLT,STisweakininducingsomeDNAsynthesis-andprecursor-producingenzymessuchasthymidinekinase(unpublished).(ii)WefoundearlierthatbothLTandSTarerequiredtoinducesufﬁcientlyhighlevelsofcyclinE/cdk2activity(Schu¨chnerandWintersberger,1999).CyclinE/cdk2isessentialforSphaseinductioninmostvertebratecells.(iii)BytargetingPP2A,anenzymethatisinvolvedinmanyFigure4EffectofLTandSTonthemcm6andmcm7promoters.Transientco-transfectionassayswereperformedusingmcm6andmcm7promoter-luciferaseconstructsandLTorSTexpressingplasmids.FordetailsseeMaterialsandmethods.TheequalexpressionofthewildtypeandmutatedviralproteinswasveriﬁedbyimmunoblottingusingapolyclonalantibodydirectedtowardstheLT/STcommonregionattheN-terminioftheviralproteinsFigure5Inductionoftheneuroﬁbromatosisgene2.TheantibodyusedforimmunoblottingwasNF2(sc-331)fromSantaCruzModiﬁcationofgeneexpressionbyTantigensBKluckyetal4718Oncogenecellularregulatoryprocesses,STmaynotonlyaffectreactionsthatfavorSphaseinductionbutalsosomethathinderthisprocessanditmayrequireLTtoneutralizetheseeffects.WedonotwanttoimplythatallofthegenesderegulatedbytheviralTantigensaredirecttargetsoftheseproteins;theexpressionofsomeofthegenesmaybeaffectedbysecondaryreactionstogeneproductsup-ordown-regulatedbytheTantigens.Still,theirderegulationinquiescentcellsdoesdependontheactivityoftheviralproteins.Anexampleisc-myc,whichwefoundtobestronglyupregulatedbySTbutwhichitselfisanimportanttransactivator.Moreover,theproductsofsomeofthegenesderegulatedbyLTorSTmayhavenoroleinSphaseinductionbuttheymaynonethelesscontributetotumorigenesis.Tumorforma-tionwasoftenconsideredtobeanaccidentalreactionfollowingvirusinfection,initiatedbythecompetenceoftheviralproteinstointerferewithgrowthcontrolandapoptosis.However,asPyisreplicatingratherslowly,theformationoftumorsmayhaveevenbeenofevolutionaryadvantageforthevirus,iftumorcellscreatelonger-lastingconditionsfavorableforvirusreplication.MaterialsandmethodsCellcultureandstabletransfectionsSwiss3T3ﬁbroblastsandderivedcelllinesconditionallyexpressingthePyLTorthePySTantigenunderthecontrolofthedexamethasone-inducibleMMTVpromoter(Ogrisetal.,1992)weregrowninDulbecco’smodiﬁedEaglesmediumcontaining10%fetalcalfserum,penicillin(60mg/ml)andstreptomycin(100mg/ml)ina7.5%CO2atmosphere.Whenthecellsreached80%conﬂuency,theywerearrestedbyserumFigure6UpregulationofthegenesfortheGPCRandformyosin.TheoligonucleotidesusedforthePCRreactionsaredescribedinMaterialsandmethodsFigure7Strongrepressionofthetumorsuppressorproteinscadherin11anddecorinbySTandLTantigens.Theantibodyusedintheimmunoblotofcadherin11isdescribedinMaterialsandmethodsModiﬁcationofgeneexpressionbyTantigensBKluckyetal4719Oncogenedeprivation(ﬁnalconcentrationofFCS0.2%)for72h.Thecellsweretheninducedwithdexamethasoneataﬁnalconcentrationof10 6mol/lfor28h.RNAextractionTotalRNAwasisolatedusingTRIzolreagent(LifeTechnol-ogies/GIBCO-BRL)asrecommendedbythesupplier.MicroarraypreparationThemousemicroarraysusedcontainedasetof17000sequenceveriﬁedmousecDNAclonesprintedontopolyly-sine-coatedslides.Priortouse,thearrayswereUV-cross-linked,rehydratedinwatersteamandchemicallyblockedusing1.37gofsuccineanhydride,90mlN-methyl-pyrrolidoneand10mlof0.2MboricacidpH8.0for15min.Afterblocking,theslideswererinsedin0.1%SDSandprehybri-dizedwithprehybridizationbuffercontaining210mlforma-mide,120ml20SSPE,60ml50Denhardts,6mlsalmonspermDNA(10mg/ml),190mlwaterand15ml20%SDSat501Cfor1h.FluorescentprobepreparationIntotal,100mgRNAin17mlwaterwasprimedwith2mloligo-dT12 18-primer(500mg/ml)at651Cfor5min.Reversetranscriptionwasperformedinamixturecontaining8ml5ﬁrst-strandreactionbufferprovidedwithSuperScripttIIRNaseH Reversetranscriptase(InvitrogenLifeTechnolo-gies),4ml100mMdithiothreitol,4mlof10dNTP(5mMdATP,dCTP,dGTPand2mMdTTP),1mlRNasin(40U/mlPromega),2mlSuperScripttIIRNaseH Reversetranscrip-tase(200U/mlInvitrogenLifeTechnologies),4mlofCy3-dUTPorCy5-dUTP(1nM/mlAmershamPharmacia)andincubatedat421Cfor60min,followedbytheadditionofanother1mlSuperScripttIIRNaseH Reversetranscriptaseforanadditional1hincubation.Thereactionwasstoppedbyincubationat941Cfor3min.TheremainingRNAwaseliminatedbyadding2mlRNaseONEt(6U/ml,Promega),5ml10RNaseONEtreactionbufferandincubatingat371Cfor10min.TheCy3-dUTPandCy5-dUTPlabelledprobeswerepooledandprecipitatedwithblockingsolutioncontain-ing3mgpoly(dA)40 60,6mgtRNA,15mgmouseCot1DNA,33ml10mol/lammoniumacetateand330ml96%ethanolat 801Cfor20min.Thepelletwaswashedwith400ml80%ethanol,dissolvedin10.5mlH2Oandthenmixedwith6ml20SSPE,1.5ml50Denhardtssolution,10.5mlformamideand0.75ml20%SDS.Theprobewasdenaturedat941Cfor1minfollowedbyprehybridizationat501Cfor1h.Itwasthenaddedtothemicroarrayslidesandincubatedat501Covernight.DataanalysisAfterthehybridization,theslideswerewashedin1SSC,0.1%SDS,followedbywashingwith0.2SSC,0.1%SDSandﬁnally0.2SSC.AfterdryingbycentrifugationthemicroarrayswerescannedwithaGenePix4060scanner.AnalysiswasperformedusingGenePixPro4.1microarrayinformationmanagementsystem(JMIMS)developedbyVolkerLeidlandGeraldLo¨fﬂer(ResearchInstitutofMolecularPathology,Vienna).RT–PCRIntotal,10mgRNAwasreversetranscribedtoﬁrst-strandcDNAusingoligo-dT-primerandRevertAidtM-MuLVReverseTranscriptase(MBI),either1/40or1/80wasusedforPCR.Thefollowingprimerswereused:cyclinD1:forward50-CTGTGCGCCCTCCGTATCTTA-30,reverse50-GGCGGCCAGGTTCCACTTGAG-30;mcm6:forward50-TGCACGAGCCTCTTCCCTACT-30,reverse50-TCCCGCATGTCCATCTTATCA-30;mcm7:forward50-AGGCGCTGCTGCTGCTTCTG-30,reverse50-GCCGGCTGTGCTGGTGGAC-30;LTforward50-GAGAGCGGCCACAGTCCAC-30,reverse50-ATCGGGCTCAGCAACACAAG-30;ST:forward50-CAGGCATATAAGCAGCAGTC-30,reverse50-CATCTCGGGTTGGTGTTC-30;Neuroﬁbromatosis2:forward50-AAGCAGCCCAAGACATTCA-30,reverse50-CTCGGGAGGGCAGTAGAC-30;Gprotein-coupledreceptor:forward50-TGCCCCTGCTCCTGGTGATTG-30,reverse50-TAGGCGCAGGCTGGCTTCGTG-30;Myosinforward50-TGGAAGTCCGGCGGCAGAGTC-30,reverse50-CCGGGGGCGAGGCTTGTAAC-30;cadherin11:forward50-ACCCCAAGGCACTCTCCAACC-30;reverse50-TCACCACCCCCTTCATCATCATAG-30;c-Myc:forward50-GCCCGCGCCCAGTGAGGATA-30,reverse50-GCGGCGGCGGTGAGGTC-30;decorin:forward50-CCCCTACCGATGCCAGTGT-30,reverse50-TTGCCGCCCAGTTCTATGAC-30;b-actinforward50-TGGCACCACACCTTCTACAATGAG-30,reverse50-CAAGAAGGAGGCTGGAAAAGAG-30.PCRcycleconditionswerethefollowing:initialdenatura-tionwasfor2minat951Cthiswasfollowedby20–25cyclesconsistingof1.5minat951C,1.5minforannealing(annealingtemperatureswereadjustedforeachprimerpair)and2minat721Cforsynthesis.DilutionsofcDNAwereperformedtodeterminethelinearrangeforeachprimerpair.PCRproductswereresolvedona1.5%agarosegelcontainingethidiumbromideandwerevisualizedwithUVlight.Real-timePCRQuantitativePCRwasperformedusingLightCyclerFastStartDNAMasterSYBRGreenIKitasrecommendedbythesupplier(Roche).ThesameprimersasdescribedinRT–PCRwereusedtoverifytheexpressionoftheselectedgenes.Theb-actingenewaschosenfornormalizationofthedata.ImmunoblottingAfter72hserumstarvationand28hinductionwithdexa-methasone,cellswereharvestedandlysedinbuffer(20mMTris-Cl(pH8.0),100mMNaCl,1mMEDTA,0.5%NP-40)containingcompleteproteaseinhibitorcocktail(BoehringerMannheim)asdescribedelsewhere(Adamczewiskietal.,1993).ProteinconcentrationwasmeasuredwiththeBioRadproteinassay(BioRad)followingthemanufacturer’sinstruc-tions.Equalamountsofproteinwereseparatedonan11%SDS–PAGE,transferredontoanitrocellulosemembraneandprobedwiththeindicatedantibodies.AntibodiesagainstMCM6(sc-9843),NF2(sc-331),cyclinD1(sc-246)andcadherin-11(sc-6463)werepurchasedfromSantaCruzBiotechnology.MCM7(Ab-1)antibodywaspurchasedfromOncogene.b-Actin(AC-74)antibodywaspurchasedfromSIGMA.LTandSTantigensweredetectedbyarabbitpolyclonalantibodydirectedagainstthecommonN-terminalregionoftheseproteins.Antibodybindingwasrevealedusingappropriateperoxidase-conjugatedsecondaryantibodies(Jackson)andECLreagents(Amersham)followingthemanufacturer’sinstruction.ModiﬁcationofgeneexpressionbyTantigensBKluckyetal4720OncogeneTransienttransfectionandluciferasereporterassaysMousemcm6andmcm7promoterswereampliﬁedbyPCRusingthefollowingprimers:mcm6:forward50-CGGGGTACCGCTTCATGGCGTATGCTT-30;reverse50CCGCTCGAGGAGGTCCATGGCGGCGCC-30;mcm7:forward50-CGGGGTACCAGGATACAGTCTTTATAGATGAG-30;reverse50-CCGCTCGAGCGCTGCCGGGGACGGTGT-30.TheampliﬁedfragmentswereinsertedintothepGL3BasicVector(Promega).AsynchronouslygrowingREF52cellswereseededatadensityof5104cellspersix-wellplate.Thenextday,thecellsweretransfectedwithpolyethylenimine(PEI25000)togetherwithplasmidcarryingtheinformationforLTorST(wildtypeormutants)undertheCMVpromoterandaplasmidexpressingb-galactosidaseasdescribedpreviously(Schu¨chneretal.,2001).Subsequently,thecellswerearrestedbyserumdeprivation(0.2%serum)for48h.Cellswerethenharvestedandluciferaseactivitywasmeasuredintheassaybuffer(25mMTricinepH7.8,0.5mMEDTA,0.54mMNa-Tripolypho-sphate,16.3mMMgSO47H2O,0.1%TritonX-100,4.6mMLuciferin,1.2mMATPand5.6mMDTT)usinganAuto-Luminat.Tonormalizethetransfectionefﬁciency,b-galacto-sidaseactivitywasmeasuredasdescribedinSambrooketal.(1989).Theproteinconcentrationwasdeterminedandlikewiseusedfornormalization.AnaliquotofeachextractwasusedfordeterminationofthelevelofTantigenbyimmunoblotting.AcknowledgementsThisworkwassupportedbytheFondszurFo¨rderungderwissenschaftlichenForschung.ReferencesAdamczewiskiJP,GannonJVandHuntT.(1993).J.Virol.,67,6551–6557.BellSPandDuttaA.(2002).Ann.Rev.Biochem.,71,333–374.BenjaminT.(2001).Virology,289,167–173.BikelIandLoekenMR.(1992).J.Virol.,66,1489–1494.CampbellKS,AugerKR,HemmingsBA,RobertsTMandPallasDC.(1995).J.Virol.,69,3721–3728.CollerHA,GrandoriC,TamayoP,ColbertT,LanderES,EisenmanRNandGolubTR.(2000).Proc.Natl.Acad.Sci.USA,97,3260–3265.DamaniaB,LiebermanPandAlwineJC.(1998).Mol.Cell.Biol.,18,3926–3935.EcknerR,LudlowJW,LillNL,OldreadE,AranyZ,ModjtahediN,DeCaprioJA,LivingstonDMandMorganJA.(1996).Mol.Cell.Biol.,16,3454–3464.Felton-EdkinsZAandWhiteRJ.(2002).J.Biol.Chem.,277,48182–48191.FernandezPC,FrankSR,WangL,SchroederM,LiuS,GreenJ,CocitoAandAmatiB.(2003).GenesDev.,17,1115–1129.FrostJA,AlbertsAS,SonntagE,GuanK,MumbyMCandFeramiscoJR.(1994).Mol.Cell.Biol.,14,6244–6252.GottliebKAandVillarrealLP.(2001).Microbiol.Mol.Biol.Rev.,65,288–318.HahnWC,CounterCM,LundbergAS,BeijersbergerRL,BrooksMWandWeinbergRA.(1999).Nature,400,464–468.HahnWC,DessainSK,BrooksMW,KingJE,ElenbaasB,SabatiniDM,DeCaprioJAandWeinbergRA.(2002).Mol.Cell.Biol.,22,2111–2123.KinoT,TakeshimaH,NakaoM,NishiTandYamamotoK.(2001).GenesCells,6,441–454.KresseH.andScho¨nherrE.(2001).JCell.Physiol.,189,266–274.LecandaF,ChengS-L,ShinCS,DavidsonMK,WarlowP,AvioliLVandCivitelliR.(2000).JCell.Biochem.,77,499–506.LoekenM,BikelI,LivingstonDMandBradyJ.(1988).Cell,55,1171–1177.LoekenMR.(1992).J.Virol.,66,2551–2555.LukasJ,Mu¨llerH,BartkovaJ,SpitkovskyD,KjerulffAA,Jansen-Du¨rrP,StraussMandBartekJ.(1994).J.CellBiol.,125,625–638.LutchmanMandRouleauGA.(1995).CancerRes.,55,2270–2274.MenssenAandHermekingH.(2002).Proc.Natl.Acad.Sci.USA,99,6274–6279.MoranE.(1993).Curr.Opin.Genet.Dev.,3,63–70.MudrakI,OgrisE,RothenederHandWintersbergerE.(1994).Mol.Cell.Biol.,14,1886–1892.NemethovaMandWintersbergerE.(1999).J.Virol.,73,1734–1739.OgrisE,MudrakIandWintersbergerE.(1992).J.Virol.,66,53–61.OgrisE,MudrakIandWintersbergerE.(1993a).Oncogene,8,1277–1283.OgrisE,RothenederH,MudrakI,PichlerAandWintersber-gerE.(1993b).J.Virol.,67,1765–1771.OhtaniK,IwanagaR,NakamuraM,IkedaM-a,YabutaN,TsurugaHandNojimaH.(1999).Oncogene,18,2299–2309.PipasJM.(1992).J.Virol.,66,3979–3985.PorrasA.,BennetJ,HoweA,TokosK,BoukN,HengleinB,SathayamangalamS,ThimmapayaBandRundellK.(1996).J.Virol.,70,6902–6909.PorrasA,GaillardSandRundellK.(1999).J.Virol.,73,3102–3107.SambrookJ,FritschEFandManiatisT.(1989).MolecularCloning:ALaboratoryManual,2ndednColdSpringHarborLaboratoryPress:ColdSpringHarbor,NY.Schu¨chnerS,NemethovaM,BelisovaA,KluckyB,HolnthonerWandWintersbergerE..(2001).J.Virol.,75,6498–6507.Schu¨chnerSandWintersbergerE.(1999).J.Virol.,73,9266–9273.ShinCS,LecandaF,SheikhS,WeitzmannL,ChengS-LandCivitellyR.(2000).J.CellBiochem.,78,566–577.Sta¨nderM,NaumannU,WickWandWellerM.(1999).CellTissueRes.,296,221–227.SonntagE,FedorovS,KambayashiC,RobbinsD,CobbMandMumbyMC.(1993).Cell,75,887–897.TsurugaH,YabutaN,HosoyaS,TamuraK,EndoYandNojimaH.(1997).GenesCells,2,381–399.WatanabeG,HoweA,LeeRJ,AlbaneseC,ShuI-W,KarnezisAN,ZonL,KyriakisJ,RundellKandPestellRG.(1996).Proc.Natl.Acad.Sci.USA,93,12861–12866.YuJ,BoyapatiAandRundellK.(2001).Virology,290,192–198.ModiﬁcationofgeneexpressionbyTantigensBKluckyetal4721Oncogene